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1232Background: Postoperative retrosternal adhesion increases the risk of cardiac injury during cardiac reoperation.
We created a novel biodegradable glue called ‘‘Lydex’’ that is derived from food additives. The purpose of this
study is to evaluate this new biomaterial’s biocompatibility and its preventive effect on retrosternal adhesion.
Methods:We performed a median sternotomy and anterior pericardiectomy on Japanese white rabbits, and then
closed the chest (control, group 1; n¼ 12), implanted an expanded polytetrafluoroethylene membrane (group 2;
n ¼ 12), or applied Lydex (group 3; n ¼ 12) before closure. After 4 weeks, we evaluated macroscopic adhesion
(each group; n ¼ 6) and microscopic findings for fibrosis and macrophage infiltration (each group; n ¼ 6).
Results: In group 3, the retrosternal adhesion score was significantly lower than in group 1 (P ¼ .0022). There
was no significant difference between groups 2 and 3. The fibrotic area ratio was significantly lower in group 3
than in groups 1 and 2 (P<.001 vs group 1; P<.001 vs group 2). In group 3, the macrophage count was sig-
nificantly lower than in group 2 (P<.001) and almost equal to that in group 1.
Conclusions: Our findings indicate that Lydex reduces retrosternal adhesion and attenuates the progression of
fibrosis with excellent biocompatibility. Lydex is a next-generation substance for safer cardiac reoperation, with
excellent capability for preventing adhesion, biocompatible and biodegradable properties, and lower potential
for viral infections related to human plasma or other animal-derived products. (J Thorac Cardiovasc Surg
2013;146:1232-8)In the field of cardiac surgery, it is reported that reoperation
is closely related to increased hospital mortality.1 Postoper-
ative retrosternal adhesion increases the risk for cardiac in-
jury and bleeding during cardiac reoperation, especially at
the time of resternotomy.2,3 It is widely known that
closure of the pericardium at the initial operation reduces
the risk of injury on reoperation. However, there are
situations in which surgeons cannot close the pericardium,
such as coronary artery bypass grafting with internal
thoracic artery grafts or operations performed in patients
with severe heart failure. Furthermore, in pediatric cardiac
surgery for congenital heart disease, patients may require
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The Journal of Thoracic and Cardiovascular SurSurgeons have used a variety of biological or synthetic
materials as a substitute for the pericardium to resolve retro-
sternal adhesion in such situations; these include expanded
polytetrafluoroethylene (ePTFE) membranes,4 silicone rub-
bers,5 glutaraldehyde-treated bovine or porcine pericardium
xenografts,6,7 and others. However, several disadvantages,
such as dense adhesion or severe inflammation, have been
reported with the use of pericardial substitutes.8 Further-
more, the application of nondegradablematerial as a pericar-
dial substitute may increase the risk of mediastinitis, one of
the critical complications after cardiac surgery, because of
colonization of infective microorganisms on the material.9
Many researchers have reported that bioabsorbable mem-
branes effectively prevented the formation of retrosternal
adhesion in experimental studies.10-13 However, these
membranes have never been widely used in the clinical
setting, possibly because of insufficient clinical evidence
on their beneficial effects or safety. Furthermore, materials
made from human plasma or other animal-derived products
may hold risks for viral infection.
We recently created a novel bioabsorbable glue called
‘‘Lydex,’’ which is a newly developed chemical compound
derived from the food additives dextran and ε-poly (L-ly-
sine).14 Dextran is a polysaccharide that is widely used as
a plasma volume expander and thickener in the clinical set-
ting. ε-Poly (L-lysine) is a small natural homopolymer of the
essential amino acid L-lysine and is used as an antibacterial
agent. As food additives, dextrans are used as coating agents
in food-contact surfaces, thickening agents, stabilizers, orgery c November 2013
Abbreviation and Acronym
ePTFE ¼ expanded polytetrafluoroethylene
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vative in multiple foods, including several staples in the
Asian diet, such as sushi or boiled rice.15Wehave previously
reported the effectiveness of the biodegradable glue as
a novel surgical sealant for lung air leakage14 or an attach-
ment medium for sustained release of antibiotics or
antiarrhythmic drugs in experimental animal models.16-18
The purpose of this study is to examine the effect of
the biodegradable glue on retrosternal adhesion and,
using a rabbit pericardiectomy model, to evaluate the
inflammatory and fibrogenic capacity and biocompatibility
of the glue for wide clinical application of this new
material in cardiac surgery.
MATERIALS AND METHODS
The study protocol was approved by the Kyoto University Ethics Com-
mittee for Animal Research. All animals received humane care in compli-
ance with the guidelines prescribed in the Principles of Laboratory Animal
Care, formulated by the National Society for Medical Research, and the
Guide for the Care and Use of Laboratory Animals, created by the Institute
of Laboratory Animal Resources of the National Research Council and
published by the National Academy Press (revised 2011).
New Absorbable Glue: Lydex
The absorbable glue called ‘‘Lydex’’ is made of the plant-derived food
additives dextran and 10% ε-poly (L-lysine) solution; both are approved by
the US Food and Drug Administration. The production process of the bio-
degradable glue has been described in detail.14 In brief, dextran was dis-
solved in distilled water. Sodium periodate was dissolved in water, and
this solution was added to the previously mentioned dextran solution.
The aldehyde groups were introduced by periodate oxidation of dextran
(Malaprade oxidation). Recovered aldehyde dextran (molecular weight,
75 KDa) was mechanically crushed into powder. Meanwhile, succinic an-
hydride was added to ε-poly (L-lysine) solution (10 w/w%) (PL solution).
The PL solution was dyed with brilliant blue FCF (50 ppm) (Wako Pure
Chemical Industries, Ltd, Osaka, Japan) for visualization in vivo; 1 mL
of PL solution was stored in each cylinder of a dual-syringe device at
4C until use. For gel formation, the aldehyde dextran and PL solution
were mixed at 25C. The gel formation started within 10 seconds and
was complete within 60 seconds of the time of mixture.
Preparation of Rabbit Pericardiectomy Model
A total of 39 Japanese white rabbits weighing 3.2 to 4.0 kg were used.
General anesthesia was induced by intravenous injection of ketamine hy-
drochloride (5 mg/kg) and sodium thiopental (15 mg/kg). Rabbits were im-
mediately intubated and connected tomechanical ventilation (tidal volume,
10 mL/kg; respiratory rate, 30 cycles/min). Anesthesia was maintained
with isoflurane (1.0%-2.5%). Intravenous antibiotics (100 mg/kg of cefa-
zolin) were administered 30 minutes before the skin incision. The chest
hair was shaved, and the skin was disinfected with iodine-alcohol solution.
Each rabbit was placed in the supine position, and a midline skin incision
was made from just below the suprasternal notch to the xiphoid process. A
median sternotomy was performed with surgical scissors while lifting the
sternum; care was taken not to injure the pericardium or pleura. A neonateThe Journal of Thoracic and Carsternal retractor was carefully applied, and the visceral pleura and the peri-
cardium were resected as much as possible. The pericardium between the
bilateral phrenic nerves was resected as much as possible (pericardiec-
tomy). In group 1 (n ¼ 12), the pericardial defect was left as a control.
In group 2 (n ¼ 12), the excised pericardium was substituted with
a 0.1-mm–thick ePTFE membrane, which was partly fixed to the edge of
the pericardium with 6-0 polypropylene stitches, allowing the fluid not to
pool at the retrosternal space. In group 3 (n ¼ 15), the biodegradable
glue was applied to the site of the excised pericardium, that is, the epicar-
dium of the right ventricle was coated with the glue. The sternum was
closed with 6 interrupted 3-0 polyglactin sutures. The muscle and skin
were closed by interrupted 5-0 polypropylene sutures. The inhalation of
isoflurane was terminated, and the rabbits were gently recovered with ven-
tilatory support. Intravenous antibiotics (100 mg/kg of cephazolin) were
administered again.
Macroscopic Evaluation for Retrosternal Adhesion
Resternotomy was performed 4 weeks after the initial operation. The
resternotomywas carefully performedwith surgical scissors. Two indepen-
dent researchers evaluated the macroscopic adhesion in the retrosternal
space (n ¼ 6 for each group; midterm evaluation). For the evaluation, the
adhesion score established by Heydorn and colleagues19 was used. In brief,
the degree of adhesion was quantitatively classified from 0 to 4 with mod-
ification as follows: 0 ¼ no adhesion; 1 ¼ trivial adhesion that could be
readily separated by finger dissection; 2 ¼ mild adhesion requiring blunt
dissection; 3 ¼ severe adhesion requiring sharp dissection; and
4 ¼ undissectable (bleeding occurred from the heart).
Microscopic Evaluation
The rabbits were killed 4 weeks after the initial operation. For micro-
scopic evaluation, the en bloc thorax, including the sternum, entire heart,
and bilateral lungs, was removed through a midline skin incision (n ¼ 6
for each group; midterm evaluation). The same procedure was conducted
12 weeks after the initial operation for some of the rabbits in group 3,
the biodegradable glue group (n ¼ 3; long-term evaluation).
For histologic examination, the samples were divided along the midline
and fixed in 10% formaldehyde, embedded in paraffin, and sliced. The sec-
tions were subjected to Masson trichrome stain for the assessment of fi-
brous reaction. The fibrotic area was automatically detected with
a computer-based method. Three random high-magnification (3200)
views for a Masson trichrome stain section (corresponding to 1 rabbit)
were subjected to automatic detection of green fibrotic area using
BZ-9000 Software (Keyence Corp, Osaka, Japan), and the fibrotic area ra-
tio was calculated as the average of the values of 3 views.
For the evaluation of biocompatibility of the pericardial substitute, we
counted the number of macrophages in the retrosternal space for 5 fields
with a magnification of 3400 for each rabbit sample. We used mouse
monoclonal anti-rabbit macrophage antibody RAM11 (Dako, Glostrup,
Denmark; code No. M0633) for the immunostaining of macrophages.
Statistics
We used SPSS II for Windows (v 11.0.1J; SPSS Inc, Chicago, Ill) as the
statistical software. The results were described as the mean  standard
deviation. Comparisons among the 3 groups were conducted by 1-way
analysis of variance with Tukey’s test as the post hoc.
RESULTS
Effect of the Biodegradable Glue on Retrosternal
Adhesion
Four weeks after the initial operation (midterm), the mac-
roscopic adhesion in group 2 (ePTFE) and group 3 (Lydex,
the biodegradable glue) was attenuated compared with thatdiovascular Surgery c Volume 146, Number 5 1233
FIGURE 1. The effect of the biodegradable glue on retrosternal adhesion. A, Representative macroscopic view at the evaluation of retrosternal adhesion 4
weeks after the initial operation (midterm). Note that group 1 (control; left) showedmore severe adhesion compared with group 2 (ePTFE;middle) and group
3 (Lydex; the biodegradable glue; right). Arrow in the middle indicates excised ePTFE membrane. B, Adhesion score (n ¼ 6 for each group). **P<.01.
***P<.001. ePTFE, Expanded polytetrafluoroethylene; N.S., not significant.
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macroscopic views recorded before dissection of retroster-
nal adhesion). The adhesion scores were 3.17  0.75 in
group 1, 1.17  0.41 in group 2, and 1.50  0.84 in group
3 (Figure 1, B). The retrosternal adhesion score in group 3
was significantly lower than in group 1 (P ¼ .0022). How-
ever, there was no significant difference between scores for
groups 2 and 3 (P ¼ .69). These results indicate that the
ePTFE membrane and application of the biodegradable
glue significantly reduced the retrosternal adhesion to the
same extent 4 weeks after the pericardiectomy.Effect of the Biodegradable Glue on Fibrosis
Representative sections of Masson trichrome staining of
each group at 4 weeks after the initial operation (midterm)
are shown in Figure 2, A. Severe fibrous adhesion was ob-
served between the sternum and the myocardium, and no
pericardial space was observed in group 1. In group 2, al-
though the retrosternal fibrosis was denser than that in
group 1, fibrosis-free space was observed on both sides of
the ePTFE membrane. In group 3, retrosternal fibrosis
was diminished compared with groups 1 and 2, and pericar-
dial space was observed. However, the glue remained on the
epicardium, and granulomatous tissue formation was ob-
served around the residual glue. The fibrotic area ratio1234 The Journal of Thoracic and Cardiovascular Surwas 50.3%  12.1% in group 1, 64.5%  11.1% in group
2, and 22.0%  8.1% in group 3 (Figure 2, B). In group 2,
the fibrotic area ratio was higher than in group 1 but not sta-
tistically significant (P ¼ .08). However, the fibrous reac-
tion score in group 3 was significantly lower than in
group 1 (P< .001) or group 2 (P< .001). This indicates
that the biodegradable glue attenuates the progression of fi-
brosis after the initial operation, whereas ePTFE membrane
implantation shows a tendency for promotion of fibrosis. In
all observed rabbits 12 weeks after the glue implantation
(long-term, n¼ 3), the residual glue and granulomatous tis-
sue observed with midterm section disappeared, and no pro-
gression of adhesion or fibrosis was observed (Figure 2, C).
This result indicates that the glue degrades with time and
that implantation does not promote adhesion because of
chronic inflammation.Biocompatibility of the Biodegradable Glue
Representative sections of RAM11 staining of each
group at 4 weeks after the initial operation (midterm) are
shown in Figure 3, A. A prominent infiltration of macro-
phages was observed in the section of group 2 compared
with the other groups. The macrophage counts were
31.0  13.7 in group 1, 85.7  27.7 in group 2, and
30.0  6.8 in group 3 (Figure 3, B). The number ofgery c November 2013
FIGURE 2. The effect of the biodegradable glue on fibrosis. A, Representative Masson trichrome staining (4 weeks after initial operation; midterm) (mag-
nification:3100). Magnification of retrosternal region (broken square) is shown (lower right).Green area indicates fibrotic tissue. Arrows in themiddle and
to the right indicate pericardial cavity. Red arrowheads in themiddle indicate ePTFEmembrane. Black arrowheads in themiddle indicate granulation tissue
around the ePTFEmembrane. B, Fibrotic area ratio (n¼ 6 for each group). ***P<.001. C, RepresentativeMasson trichrome staining in group 3 (Lydex, the
biodegradable glue). Sections of all rabbits included in this long-term evaluation (12 weeks after initial operation) are shown (n ¼ 3; from No. 1-3). Arrow
indicates pericardial cavity. S, Sternum; R, retrosternal space; M, myocardium; A, adipose tissue; L&G, Lydex and granulation tissue; ePTFE, expanded
polytetrafluoroethylene.
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group 1 (P ¼ .00035). However, the number of macro-
phages in group 3 was significantly lower than in group 2
(P ¼ .00030). There was no significant difference between
counts for groups 1 and 3. These results indicate that the
biodegradable glue causes little foreign-body reaction on
retrosternal application and possesses excellent biocompat-
ibility compared with ePTFE membrane.
DISCUSSION
In cardiac reoperations, dense retrosternal adhesions be-
tween the sternum and the heart can induce fatal bleedingThe Journal of Thoracic and Carduring resternotomy, as well as right ventricular dysfunc-
tion or decreased coronary artery bypass graft patency. Con-
sequently, it is said that the postoperative retrosternal
adhesion increases total surgical risk during reoperation.2,3
Therefore, efforts made to prevent subsequent adhesion
during an initial operation may lead to an improvement in
surgical outcome.
Postoperative adhesion, which is formed after initial op-
eration, is scar formation as the end stage of the inflamma-
tory response. It is also known as the process of wound
healing. Wound healing is classified into 3 phases: inflam-
mation, proliferation, and maturation.20 The initial injurydiovascular Surgery c Volume 146, Number 5 1235
FIGURE 3. The biocompatibility of the biodegradable glue. A, Representative RAM11 staining for macrophages (4 weeks after initial operation; midterm)
(magnification:3400). Brown spots indicate macrophages (arrowheads). B, Count of macrophages (n¼ 6 for each group; each count is the average count of
5 random fields with 3400 magnification macroscopic view). ***P<.001. ePTFE, Expanded polytetrafluoroethylene; N.S., not significant.
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of clots in the surface of the wound, leading to inflamma-
tion. In the proliferative phase (within the initial 24-72
hours from injury), formation of granulation tissue takes
place because of proliferation and migration of connective
tissue cells, fibroblasts, or vascular endothelial cells. Mac-
rophages are the main cell components involved with tissue
repair as the main source for multiple growth factors, which
trigger proliferation of fibroblasts and control migration of
fibroblasts to the site of injury. In the maturation phase, the
granulation tissue scaffolding is converted into avascular
scar, composed of spindle-shaped fibroblasts, dense colla-
gen, and fragments of elastic tissue. By the end of the first
month, the scar is made up of acellular, fibrotic connective
tissue devoid of inflammatory infiltration and induces local
adhesion. For the purpose of attenuating dense retrosternal
adhesions, it is essential to suppress the progression of the
vicious inflammatory response described earlier.
In this study, we demonstrated that the biodegradable glue,
a new material derived from food additives, significantly re-
duced postoperative adhesion. In a rabbit model of pericar-
diectomy, application of the glue prevented retrosternal
adhesion as well as ePTFE membrane. Furthermore, histo-
logic studies revealed that application of the glue suppressed
fibrosis and foreign-body reactionafter the surgical procedure.
The preventive effect of the biodegradable glue on adhe-
sion was comparable to that of ePTFE membrane. ePTFE
membrane is the most commonly used synthetic pericardial
substitute; it serves as a barrier between sternum and1236 The Journal of Thoracic and Cardiovascular Surepicardium and makes re-sternotomy safe. Thus, our results
suggest that the application of the glue may profit cardiac
surgeons in the clinical setting. One of the disadvantages
of ePTFE membrane is severe inflammatory reaction and
diffuse fibrosis around the membrane, as has been observed
in our studies. In the present study, fibrosis and foreign-
body reaction after application of the biodegradable glue
were almost comparable to those of the control. These re-
sults suggest that application of the glue inhibits the
wound-healing process. The mechanism of the glue in pre-
venting postoperative adhesion should be examined further.
The present study also demonstrated the excellent bio-
compatibility of the biodegradable glue. After implantation,
macrophages recognize materials as foreign substances and
then activate and trigger phagocytosis for the substances.
When implanted foreign substances such as sutures or arti-
ficial materials (eg, ePTFE, the biodegradable glue studied)
are large enough that phagocytosis by a single macrophage
is precluded, the macrophages remain in the periphery of
the substances. Their presence indicates the continuation
of chronic inflammation, which is distinct from granuloma-
tous inflammation. Therefore, the degree of chronic inflam-
mation in a foreign-body reaction is proportional to the
number of macrophages in the periphery of the substance.
Conversely, the number of macrophages is inversely pro-
portional to the degree of biocompatibility of the implanted
foreign substances. In the present study, the number of mac-
rophages in the biodegradable glue group was significantly
lower than in the ePTFE group and almost equal to thegery c November 2013
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with the implanted glue (4-week and 12-week models),
there was no sign of constrictive pericarditis, a pathologic
consequence of chronic inflammation. These results indi-
cate that the glue causes the least chronic inflammatory re-
action and possesses excellent biocompatibility, with
a suppressed foreign-body reaction after implantation. Fur-
thermore, it is confirmed in the present study that the glue
does not remain 12 weeks after implantation. Another re-
cent study showed that the biodegradable glue was fully ab-
sorbed after 28 days of local administration in the pleural
cavity of rats.21 Thus, it can be concluded that the glue
has excellent biocompatible and biodegradable properties.
In regard to the safety of the biodegradable glue for clin-
ical application, it is likely to be safe for the human body
with regard to cell toxicity, as shown by Nakajima and col-
leagues.22 Furthermore, because the glue is made of food
additives, there must be a limited risk for viral infections,
such as hepatitis virus or human immunodeficiency virus,
compared with the risk from materials derived from human
plasma or other animal-derived products.
Another advantage of the biodegradable glue is the low
cost. The main materials of the glue are derived from
food additives and available at a lower cost compared
with human or animal blood–derived materials, which
may be favorable for worldwide use of this material.
For clinical application of the biodegradable glue, we
need further experiments using large-scale animals (eg, por-
cine model) that would be more similar to the clinical set-
ting compared with the rabbit model used in the present
study. In the preclinical studies, the safety of the local appli-
cation of this novel material must be confirmed in addition
to the preventive effect of retrosternal adhesion.
Study Limitations
As described earlier, there are many usable materials for
the prevention of postoperative adhesion. The use of CoSeal
(Baxter Healthcare, Deerfield, Ill) has shown an excellent
outcome for the prevention of retrosternal adhesion in ran-
domized animal studies23 or observational studies in pediat-
ric cardiac surgery.24 More recently, CorMatrix (CorMatrix
Cardiovascular, Atlanta, Ga) has been applied for pericar-
dial reconstruction as extracellular matrices for tissue re-
generation.25 However, in this article, we merely
compared the properties of the biodegradable glue and
ePTFE membrane. Whereas the safety of the glue with re-
gard to the low probability of viral infection is a potent
and specific advantage of this material, there might be other
materials that have the same excellent biocompatibility and
protective effect for fibrosis formation as the glue. Further
examinations are needed to determine whether the biode-
gradable glue holds more advantages for the prevention of
retrosternal adhesion compared with other new materials,
such as CoSeal or CorMatrix.The Journal of Thoracic and CarWe suppose that the use of the biodegradable glue has
more limited possibilities for surgical wound infection be-
cause of its biodegradability, and it is advantageous com-
pared with the use of ePTFE membrane. However, we
have not closely assessed local or systemic infection in this
study. Although macroscopically apparent infection was
not observed in any rabbit included in this study, closer ex-
amination for bacterial or viral infections should have been
conducted to demonstrate superior infection resistance of
the biodegradable glue compared with ePTFE membrane.CONCLUSIONS
Lydex, a novel bioabsorbable glue derived from food ad-
ditives, is an excellent material for prevention of retroster-
nal adhesion after surgical procedures and does not
increase fibrosis or macrophage infiltration in the retroster-
nal area because of its excellent biocompatibility. The bio-
degradable glue may be an ideal material to prevent
postoperative retrosternal adhesion.References
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